Citius Oncology issues advisor warrants and amends stock incentive plan
NeutralFinancial Markets

Citius Oncology has announced the issuance of advisor warrants and amendments to its stock incentive plan. This move is significant as it reflects the company's strategy to enhance its compensation structure for advisors, potentially attracting more talent and aligning interests with shareholders. Such adjustments can be crucial for a biotech firm as it navigates the competitive landscape of oncology.
— Curated by the World Pulse Now AI Editorial System